Dr. Shaker R Dakhil MD
Hematologist-Oncologist | Hematology & Oncology
818 N Emporia St Suite 403 Wichita KS, 67214Rating
4/5
About
Dr. Shaker Dakhil is a hematologist oncologist practicing in Wichita, KS. Dr. Dakhil specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Beirut Arab University Faculty of Medicine
UniversitÈ Saint-Joseph FacultÈ de MÈdecine 1975
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Phase II study of Didemnin B in central nervous system tumors: a Southwest Oncology Group study.
- Association of immune parameters with clinical outcome in stage III colon cancer: results of Southwest Oncology Group Protocol 9009.
- Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
- An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
- Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.
- Phase II trial of dolastatin-10 in patients with advanced breast cancer.
- Von Meyenberg complexes simulating diffuse liver metastasis in rectal carcinoma.
- Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
- A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer.
- Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial.
- Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients.
- Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
- Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
- Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial.
- Malpositioned hepatic artery catheters.
Clinical Trials
- Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
- A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer
- Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
- The National Myelodysplastic Syndromes (MDS) Study
- Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
- Phase 2, Single Arm, Open Label Study of Folotyn in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With Hematological Malignancies
- A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
Treatments
- Prostate Cancer
- Melanoma
- Anemia
- Throat Cancer
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Lymphoma
- Multiple Myeloma
- Leukemia
- Aerolase® Technologies
- Extra Corporeal Shockwave Therapy
Dr. Shaker R Dakhil MD's Practice location
Practice At 818 N Emporia St Suite 403
818 N Emporia St Suite 403 -Wichita, KS 67214Get Direction
Dr. Shaker R Dakhil MD's reviews
Write ReviewPatient Experience with Dr. Dakhil
Recommended Articles
![]()
Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a CauseEveryone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...
![]()
How to Show Social Support for LymphomaA cancer diagnosis can shake an individual’s world, and not just the physical aspects of their world, but all corners of it. Although cancer attacks the body, it necessarily also affects a person’s mental and emotional state, and it can have an impact on other people close to the affected...
![]()
Living as a Hodgkin Lymphoma Survivor: Creating a New NormalNo one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...
![]()
7-year-old with Lymphoma Joins and Inspires Lacrosse TeamSports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...
![]()
The Leukemia & Lymphoma Society to Expand Mission Against Blood CancerOn July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
Nearby Providers
![]()
Dr. Nassim H Nabbout M.D.3243 E Murdock St Wichita KS 67208![]()
Dr. David B Johnson MD818 N Emporia St Wichita KS 67214![]()
Dr. Quoc V Truong MD818 N Emporia St Wichita KS 67214![]()
Dr. Dennis F Moore MD818 N Emporia St Wichita KS 67214![]()
Dr. Michael W Cannon MD818 N Emporia St Wichita KS 67214![]()
Dr. Phu V Truong MD3243 E Murdock St Wichita KS 67208
Nearest Hospitals
VIA CHRISTI HOSPITALS WICHITA, INCl
929 NORTH ST FRANCIS STREET WICHITA KS 67214